Business Wire

IAFSC

7.9.2020 15:02:20 CEST | Business Wire | Press release

Share
The Interfaith Alliance for Safer Communities Hosted A Roundtable Event - Covid-19: Faith as a Moral Framework for our Communities

The Interfaith Alliance for Safer Communities (IAFSC), an NGO established to empower faith leaders to work for the safety and security of communities, has held a successful online interfaith roundtable event with representation from 50 participants representing 7 faiths from 18 countries.

Speaking about the event, Dr. Vinu Aram (Director of Shanti Ashram and Co-Moderator of Religions for Peace) said, “I want to thank the Interfaith Alliance for Safer Communities for this meeting today. The work of the Interfaith Alliance is so important: in the disruption of the ways we worked together as communities during Covid-19, we have found that children have become more vulnerable... While every nation is trying to find its own solution, those of us who work with children have to be greater advocates for their cause.”

Chief Executive of the IAFSC, Dana Humaid, said “Faith has rarely been more important or powerful than in the current crisis. The IAFSC hosted this event in order to allow discussion and facilitate knowledge-sharing from different religions and communities on a global scale. Faith leaders have the power to assist their communities, to be advocates for those in need, to make a difference and offer comfort and also to try and reduce the suffering of people under their watch.”

The ongoing Covid-19 pandemic has been unprecedented in modern times, and has had a significant impact on the physical, mental and spiritual wellbeing of our communities. Millions have lost their jobs and are facing struggles such as hunger and homelessness. This pandemic has had unforeseen consequences as well, such as a surge in the cases of child sexual abuse as well as an increase in hate crimes based on race and religion.

Key Outcomes

The roundtable discussions aimed to address the most significant problems being faced by our communities today.

Supporting those most impacted by coronavirus in rebuilding their lives

  • We are all impacted by this pandemic, we are not all affected the same way.
  • The role of faith and faith leaders is to build, promote and invigorate a spirit of resilience.
  • When faith leaders aren’t able to contact their community and provide them with help or assistance in a difficult time, it is a challenge for everyone in the community.
  • Faith leaders have been taking on the bulk of the work in some communities.
  • We need to be careful of our blind spots, we cannot create a situation in which we overlook other communities that now need our help, such as those that may not be considered traditionally vulnerable sectors of society.

Protecting the digital dignity of children and supporting the victims and their families

  • Faith leaders can be champions in leading the prevention of sexual exploitation.
  • It is important to base our responses on data and evidence and go from there.
  • No one is an expert in the prevention of exploitation. Community is key.
  • We need to increase budgets for social and health services.
  • Family and family stability are also vital.
  • Education, mobilization, support and universal healthcare are all necessary in improving our communities.

Among others, organisations represented included: Arigatou International, ECPAT International, New York Board of Rabbis, Conference of European Rabbis, Bahá'í International Community, Peres Center for Peace and Innovation, Shanti Ashram, World Economic Forum, UNICEF, Conference of European Churches, Markaz Knowledge City (India), and Online Anti-Semitism Task Force.

Visit https://iafsc.org/

Link:

ClickThru

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Yubico Appoints Poupak Modirassari Enbom as Chief Marketing Officer to Accelerate Global Momentum and Drive Market Leadership30.3.2026 15:00:00 CEST | Press release

Yubico (NASDAQ STOCKHOLM: YUBICO), the creator of the most secure passkeys and a leading provider of hardware authentication security keys, today announced the appointment of Poupak Enbom as Chief Marketing Officer (CMO). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330278027/en/ Enbom joins Yubico at a pivotal moment as organizations worldwide accelerate the shift to phishing-resistant authentication and modern identity security in the age of AI. “We’re excited to welcome Poupak to Yubico,” said Jerrod Chong, acting chief executive officer, Yubico. “As the threat landscape evolves with AI-driven attacks and increasing automation, organizations are rethinking how they secure digital identities of both humans and AI agents at scale. She brings a unique combination of technical depth, global leadership, and customer-first mindset that will help us continue to expand our impact and support our customers and partners around

Westinghouse Celebrates Record-breaking 80 Years of Nuclear Fuel Manufacture at Springfields30.3.2026 14:00:00 CEST | Press release

Fuel manufactured at Springfields has generated enough energy to supply the UK’s electricity demand for 26 years, avoiding the emission of nearly 3 billion tonnes of CO2 The Westinghouse Springfields facility in Lancashire, UK, has marked a significant milestone as the oldest continuous nuclear fuel manufacturing site in the world, starting from its original license on the 28th, March 1946. The site was chosen by the UK Government to develop nuclear fuel for the world’s earliest civil nuclear power stations, as well as subsequent Magnox and Advanced Gas Reactors (AGR) reactors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330135973/en/ From left to right: Sophie Lemaire; Marc Chevrel; Rory O'Neill; Craig Boothby; and Robert Gofton, CEO at Nuclear Institute Across the last eight decades, the Springfields site has supported the UK nuclear fleet, manufacturing more than eight million AGR pins, sintering and pressing over 5

HistoSonics Treats First Patients Evaluating the Edison® Histotripsy System for the Treatment of Benign Prostatic Hyperplasia (BPH)30.3.2026 14:00:00 CEST | Press release

HistoSonics, the developer of the Edison® Histotripsy System and novel histotripsy therapy platform, today announced the successful treatments of the first patients in WOLVERINE, a prospective feasibility trial evaluating the Edison® Histotripsy System for the treatment of benign prostatic hyperplasia (BPH) at Prince of Wales Hospital in Hong Kong, a teaching hospital for The Chinese University of Hong Kong. The Edison System is a novel, non-invasive, image guided platform that uses the mechanical properties of focused ultrasound, called histotripsy, to destroy unwanted tissue without the need for invasive procedures, and with potentially fewer side effects than traditional, invasive therapies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330349844/en/ HistoSonics Non-Invasive Edison Histotripsy System. Image credit: HistoSonics WOLVERINE is a prospective, multi-center, single-arm feasibility trial designed to evaluate

Biocytogen Grants Taisho Pharmaceutical a License to its RenNano® Fully Human Heavy Chain-Only Antibody Discovery Platform30.3.2026 13:00:00 CEST | Press release

Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315), a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies, today announced that it has entered into a platform license agreement with Taisho Pharmaceutical Co., Ltd. (“Taisho”), granting Taisho the right to access and use Biocytogen’s proprietary RenNano® fully human heavy chain-only antibody (HCAbs) discovery platform for its internal research and development programs. Under the terms of the agreement, Taisho will leverage RenNano® mice to enable the generation and screening of fully human HCAbs in vivo and to support downstream research associated with antibody discovery. Financial terms of the agreement have not been disclosed. “We are very pleased to enter into this collaboration with Taisho,” said Dr. Yuelei Shen, President and CEO of Biocytogen. “RenNano® is a robust and powerful fully human VHH discovery platform that pro

Meiji Seika Pharma Invests in Centivax to Develop Next Generation Universal Vaccine Platform30.3.2026 13:00:00 CEST | Press release

Meiji Seika Pharma Co., Ltd. (Head Office: Chuo-ku, Tokyo, President and Representative Director: Toshiaki Nagasato) today announced a strategic investment in Centivax, Inc. (Head Office: South San Francisco, CA, USA), a biotechnology company developing next-generation vaccines and therapies for universal protection against highly diverse targets. Centivax’s lead program includes a universal seasonal influenza vaccine (Centi-Flu 01) currently in a Phase 1 clinical study. Unlike conventional seasonal flu vaccines, which must be manufactured annually based on recommended candidate vaccine viruses, Centivax’s platform focuses both antibody and cellular immune responses on conserved regions of the influenza virus that cannot mutate and are shared across strains and distant subtypes. This approach aims to generate broad, consistent, and durable immunity against both seasonal and pandemic influenza. Meiji’s strategic investment aims to accelerate the advancement of Centi-Flu 01 and further a

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye